Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
Klaus Pantel, Catherine Alix‐Panabières
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005615-e005615
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 59
Preclinical models for drug discovery for metastatic disease
Lalage M. Wakefield, Seema Agarwal, Kandice Tanner
Cell (2023) Vol. 186, Iss. 8, pp. 1792-1813
Closed Access | Times Cited: 29
Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
Αreti Strati, Athina Markou, Evgenia Kyriakopoulou, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2185-2185
Open Access | Times Cited: 26
Circulating tumour cells: The Good, the Bad and the Ugly
Mark Bates, Bashir M. Mohamed, Mark P. Ward, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 2, pp. 188863-188863
Open Access | Times Cited: 22
Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
Santhasiri Orrapin, Patcharawadee Thongkumkoon, Sasimol Udomruk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12337-12337
Open Access | Times Cited: 13
Microfluidic-SERS Technologies for CTC: A Perspective on Clinical Translation
Amin Hassanzadeh‐Barforoushi, Anastasiia Tukova, Audrey Nadalini, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 5
Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 5
Potential Application of Circulating Tumor Cell Markers to Evaluate Response to Chemotherapy in Breast Cancer Patients: A Narrative Review
I Gusti Ngurah Gunawan Wibisana
Proceedings Book of The International Conference and Exhibition on The Indonesian Medical Education Research Institute. (2025) Vol. 8, Iss. -, pp. 130-141
Closed Access
Biosensors used for anticancer therapeutics
Arpana Purohit, Sameeksha Jain, Pritish Kumar Panda
Elsevier eBooks (2025), pp. 73-91
Closed Access
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
Karl Payne, Jill Brooks, Nikolaos Batis, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 10, pp. 1590-1598
Open Access | Times Cited: 11
Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer
Emmanuel Acheampong, Rebecca C. Allsopp, Karen Page, et al.
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 234-249
Open Access | Times Cited: 4
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine
Maria Cristina Rapanotti, Tonia Cenci, Maria Giovanna Scioli, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 4
Hypoxia stimulates CTC-platelet cluster formation to promote breast cancer metastasis
Weijia Zhou, Chengjun Zhu, Peiliang Shen, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109547-109547
Open Access | Times Cited: 3
Intersecting Pathways: The Role of Hybrid E/M Cells and Circulating Tumor Cells in Cancer Metastasis and Drug Resistance
Amirali Hariri, Mina Mirian, Arezoo Khosravi, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101119-101119
Closed Access | Times Cited: 3
Minimally invasive biopsy‐based diagnostics in support of precision cancer medicine
Bo Franzén, Gert Auer, Rolf Lewensohn
Molecular Oncology (2024) Vol. 18, Iss. 11, pp. 2612-2628
Open Access | Times Cited: 2
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma
Jinyan Chen, Huigang Li, Jianyong Zhuo, et al.
Cancer Biology and Medicine (2024) Vol. 21, Iss. 11, pp. 1033-1049
Open Access | Times Cited: 2
The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma
Bojan Milošević, Bojan Stojanović, Aleksandar Cvetković, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13407-13407
Open Access | Times Cited: 5
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing
Krzysztof Pastuszak, Michał Sieczczyński, Marta Dzięgielewska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Liquid biopsy: paving a new avenue for cancer research
Keerthi Kurma, Zahra Eslami‐S, Catherine Alix‐Panabières, et al.
Cell Adhesion & Migration (2024) Vol. 18, Iss. 1, pp. 1-26
Open Access | Times Cited: 1
A Revolutionary Era in Advancing Precision Immuno-oncology; Role of Circulating Tumor Cells
Nazila Bahmaie, Özen Özensoy Güler, Ender Şi̇mşek
The Journal of Liquid Biopsy (2024) Vol. 6, pp. 100169-100169
Closed Access | Times Cited: 1
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial
Lisa Paschold, Alexander Stein, Benjamin Thiele, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006678-e006678
Open Access | Times Cited: 4
Cancer: Biology and Diagnostics
Klaus Pantel, Samir Hanash, Kathleen F. Kerr, et al.
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 1-3
Closed Access | Times Cited: 1
Carbon Ion Irradiation Activates Anti-Cancer Immunity
Makoto Sudo, Hiroko Tsutsui, Jiro Fujimoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2830-2830
Open Access | Times Cited: 1
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
Brittany McKelvey, Hillary S. Andrews, Frederick L. Baehner, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 912-912
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top